GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

RenovaCare RCAR · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

-99.00%

Close of 2 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About RenovaCare

Its shares trade under the ticker RCAR. It has been listed since 8 August 2000.

RenovaCare, Inc. operates as a development stage company, which focuses on acquisition and development of autologous cellular therapies for medical and aesthetic applications. The company is headquartered in Roseland, New Jersey. The company went IPO on 2000-08-08. The firm is focused on the acquisition, research, development and, if warranted, commercialization of autologous (using a patient’s own cells) cellular therapies that can be used for medical and aesthetic applications. The CellMist System includes a treatment methodology for cell isolation for the regeneration of human skin cells (the CellMist Solution) and a solution sprayer device (the SkinGun) for delivering the cells to the treatment area. The CellMist Solution is a liquid suspension containing a patient’s own regenerative skin stem cells. Its SkinGun is a spray device which deposits the CellMist Solution on to a patient’s wounds. Its cell isolation methodology is referred to as the CellMist process, and its cell deposition device is referred to as the SkinGun. The company isolates a patient's stem cells from a small biopsy of the patient's skin.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
8 Aug 2000
Employees
2

Leadership

Pay as last reported

  • Mr. Harmel RayatChairman of the Board, Interim President, Chief Executive Officer, Interim Chief Financial Officer, Secretary, since 1996$1
  • Dr. Robin RobinsonChief Scientific Officer$220,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • RenovaCare Inc is a biotechnology company specializing in developing innovative and advanced therapies for wound healing and skin regeneration. The company's strengths include:

Weaknesses

  • Despite its strengths, RenovaCare Inc also faces certain weaknesses that could hinder its growth and success:

Opportunities

  • RenovaCare Inc has opportunities to capitalize on the market demand and technological advancements in regenerative medicine:

Threats

  • RenovaCare Inc faces several threats that could impact its growth and competitive position in the market:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.